Close Menu

NEW YORK ─ As the coronavirus pandemic continued to attract the attention of the US Food and Drug Administration in August, the agency for the second consecutive month granted only a few 510(k) clearances for in vitro diagnostic products.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.